Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-33448-1.pdf
Reference38 articles.
1. Huang, C. F. et al. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Journal of hepatology. 62(3), 512–518 (2015).
2. Rueger, S. et al. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut. 64(10), 1605–1615 (2015).
3. Ghany, M. G. et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology. 138(1), 136–146 (2010).
4. Tamaki, N. et al. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens. PloS one. 10(9), e0137351 (2015).
5. Poynard, T., Bedossa, P. & Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 349(9055), 825–832 (1997).
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08
2. The impact of single‑nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct‑acting antiviral drugs for hepatitis C infection;Biomedical Reports;2021-12-07
3. MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective;Alimentary Pharmacology & Therapeutics;2021-03-22
4. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities;Expert Review of Precision Medicine and Drug Development;2020-06-09
5. Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases;Hepatology Research;2020-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3